Download Optimal pacing strategies for coming off CPB

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Heart failure wikipedia , lookup

Lutembacher's syndrome wikipedia , lookup

Management of acute coronary syndrome wikipedia , lookup

Cardiothoracic surgery wikipedia , lookup

Myocardial infarction wikipedia , lookup

Mitral insufficiency wikipedia , lookup

Cardiac surgery wikipedia , lookup

Cardiac contractility modulation wikipedia , lookup

Hypertrophic cardiomyopathy wikipedia , lookup

Electrocardiography wikipedia , lookup

Quantium Medical Cardiac Output wikipedia , lookup

Jatene procedure wikipedia , lookup

Heart arrhythmia wikipedia , lookup

Atrial fibrillation wikipedia , lookup

Ventricular fibrillation wikipedia , lookup

Arrhythmogenic right ventricular dysplasia wikipedia , lookup

Transcript
Aman Mahajan, MD, PhD, FAHA
Professor and Chief, Cardiac Anesthesiology
UCLA School of Medicine, Los Angeles, CA
Optimal pacing strategies for coming off CPB
Optimal pacing strategies employed after CPB enhance ventricular function with improvements in
cardiac output and tissue perfusion. Pacing is optimized for each patient by taking into consideration the
underlying electrophysiological abnormalities, as well as co-existing structural cardiac diseases. The
primary objective of rhythm stability and improved cardiac function in the post-CPB period is obtained by 1. Optimizing pacemaker lead configuration and positioning as well as capture and sensing properties
2. Appropriate programming of pacemaker timing and intervals and use of correct pacing modes
a. Adjusting pacing rate to obtain balance between cardiac output and myocardial oxygen demand
b. Maintaining optimal atrio-ventricular (AV) synchrony and AV conduction delay
c. Maximizing ventricular ejection through coordinated ventricular activation
Pacemaker lead configuration and placement
Epicardial wires (or leads) can be placed in a unipolar or bipolar configuration. In a unipolar
system a single wire (the negative anode) is connected to the epicardium, while the positive electrode is
attached at a distance in the subcutaneous tissues. The bipolar system, on the other hand, requires both the
wires (cathode and anode) to be connected to the epicardium. As the current travels a much shorter distance
between electrode tips, less electrical energy is required to bring the myocardium to threshold in a bipolar
system as compared to a unipolar system. Pacemakers also use the same epicardial wires to sense intrinsic
electrical activity; the smaller current path of bipolar electrodes makes them less susceptible to electrical
interference when performing the sensing function. For these reasons, placing bipolar wires is most
desirable before coming off-CPBi.
Site of placement of pacing wires is important both for the obtaining appropriate sensing and
pacing thresholds, and for achieving the desired mechanical activity (ejection) in the cardiac chambers.
Pacing electrode (cathode) on the cephalic atrial wall between the left and right atrial appendages, where
the Bachmann bundle indwells, provides good atrial pacing and sensing thresholdsii,iii. Right atrial
appendage is another frequently employed site for atrial pacing. For ventricular pacing, epicardial
electrodes in the RV outflow tract provide superior hemodynamics when compared to RV apical
electrodesiv. For patients with dilated LV who have severely reduced EF or conduction delays, BiV pacing
can be effectivev,vi,vii. In addition to the RV lead, another ventricular lead is placed on the LV basal
posterior-lateral wall, allowing both the ventricles to be stimulated simultaneouslyviii. Unfortunately, unlike
permanent pacemakers, no current temporary pacemaker generator allows programming of timed activation
delays between the two ventricles.
Pacemaker/Programmer timings and settings
Temporary pacing generators are typically constant-current output devices (as compared to the
permanent pacemakers that are constant-voltage devices), and are designed to function against resistances
of 300-1000 ohms. The stimulus pulse width is usually 1-2 msec. They typically allow adjustable pacing
rates (30-180/min), sensitivity settings (0.1mV-asynchronous), and current outputs (0.1 mA-25 mA).
Commonly used temporary programmers in US are- (a) Medtronic model 5348 and 5388 (Medtronic,
Minneapolis, MN, USA). (b) St Jude models 3085 and 3077, (St Jude Medical, Sylmar, CA, USA)
Rate: Pacing rate should ideally be adjusted to optimize both cardiac output and myocardial oxygen
demand. In practice, the optimal heart rate is infrequently accurately titrated to cardiac output and is usually
left at 80–90 beats/min. As the patient transitions to complete reliance on intrinsic rhythm, a period of
'backup' pacing (with the pacemaker set ~ 60-70 beats/min) can be employed. This approach allows the
patient to remain in an intrinsic rhythm until the point of significant hemodynamic compromise, while
providing the ability to continuously monitor sensing thresholds.
AV Interval: Each patient will have an optimal AV delay. Though the default value is usually
sufficient in pt with normal systolic or diastolic function, in the hemodynamically compromised patients,
adjustment of the AV delay to a real-time measure of cardiac output (such as Doppler time-velocity integral
at the aortic valve, pulse contour analysis CO, or the mixed venous oxygen saturation) may be required.
Optimal AV delay varies between 100 msec and 225 msecix.
Refractory intervals and blanking periods: All demand pacing modes incorporate various blanking
and refractory intervals that follow intrinsic or paced depolarizations during which there is essentially no
sensing. These intervals are important in preventing inappropriate sensing of after-depolarizations, far-field
potentials, and ectopic beats. These intervals can be adjusted to optimize the pacing rhythms.
Pacing or Capture thresholds: The capture threshold is the minimum pacemaker output required to
stimulate a propagated action potential in the myocardium. Pacing threshold is confirmed by setting the
pacemaker rate above the patient's intrinsic rate such that the respective chamber is being consistently
paced. The pacemaker energy output is then slowly reduced until loss of capture occurs. This current value
is the capture threshold. Typically, the output is left at twice the threshold to allow a margin of safety for
pacing. However, if the threshold is > 10 mA, the margin of safety is set to a lesser value, so as not to
accelerate fibrosis at the lead/myocardium interface. Failure to capture (or increasing pacing output needs)
is the most common problem encountered with temporary epicardial pacing. Reversing the polarity of
both bipolar and unipolar lead systems may improve capture. Conditions that might worsen capture
threshold during the weaning phase of CPB are- Myocardial ischaemia or fibrosis; Electrolyte imbalance,
particularly hyperkalaemia, acidosis and alkalosis; Post-defibrillation period; and Medications- flecainide,
propafenone, sotalol, and possibly beta blockers, lidocaine, procainamide, and verapamil.
Sensing thresholds: The sensitivity setting on the temporary pacing generator is the least amount of
current that the pacemaker is able to sense. A lower value corresponds to a greater sensitivity. To confirm
the sensitivity, the pacemaker is programmed in VVI, AAI or DDD modes and the pacing rate is set below
the intrinsic rate. The sensitivity value is slowly increased (making the pacemaker less sensitive) until the
sense indicator stops blinking and the pacing occurs asynchronously. The sensitivity value is then turned
down (making the pacemaker more sensitive) until the sense indicator blinks with each intrinsic
depolarization (P or QRS); this value defines the pacing threshold. I recommend leaving the pacing
generator programmed at half the pacing threshold to allow for detection of abnormally small signals. In
the absence of an intrinsic rhythm, it is impossible to determine the pacemaker sensitivity, in which case
the sensitivity is typically programmed to 2 mV. If the sensitivity value is too low (i.e. the pacemaker is too
sensitive), there may be inappropriate sensing of far field signals such as R or T waves, and these may
inappropriately inhibit pacing. Threshold testing can usually be performed after coming off CPB.
Typical temporary pacemaker settings
Lower rate limit (pacing rate):
PR interval/AV delay:
PVARP:
Atrial overdrive stimulation:
Atrial and ventricular output:
Atrial sensitivity:
Ventricular sensitivity:
50-60 (backup); 75–95 (pacing)
150 ms (50–300 ms)
~250 ms; or Auto- determined by rate
up to 800 ppm
10 mA (5–25 mA)
5 mV (0.4–10 mV)
5 mV (0.8–20 mV)
Understanding the various available pacing modes is important for their effective utilization in
improving cardiac function. The NASPE/BPEG nomenclature for pacing modes is described -
2
Only the first three letters are relevant for the predominantly used temporary pacemaker generators.
Single chamber pacing modes
AOO (atrial asynchronous), VOO (ventricular asynchronous)
In AOO mode, pacing stimuli to the atrium are delivered at a fixed rate, regardless of the
underlying electrical rhythm in either chamber of the heart. Ventricular activation and contraction relies on
intact AV node conduction. In majority of patients, ability to recruit atrial contraction provides an
improvement in cardiac function (SV, EF%) after CPB. This mode can be reliably employed to wean
patients from CPB if the underlying rhythm is sinus bradycardia or junctional with intact AV nodal
conduction. However, underlying competing rhythms frequently lead to uncoordinated electrical and
mechanical activity with all asynchronous pacing modes. Analogous to AOO, VOO pacing stimuli are
delivered to the ventricle at a fixed rate. Atrial contribution to ventricular filling and ejection is largely
compromised in VOO. Although it does not provide the most favorable hemodynamics for weaning from
CPB, it is sometimes employed because of convenience.
AAI (atrial demand), VVI (ventricular demand)
In AAI mode, if no intrinsic depolarization (atrial activity) is sensed by the end of a programmed
timing cycle a pacing stimulus is delivered to the atrium. However, an intrinsic atrial depolarization that is
sensed resets the timing cycle and no stimulus is delivered. AAI mode is used during weaning from CPB if
the underlying rhythm is bradycardia, but with an intrinsic atrial rate (or frequent ectopics) sufficiently fast
to compete with the programmed pacemaker rate. VVI is similar to AAI, except the sensing and pacing is
in the ventricle. As with VOO, lack of coordinated atrial contraction with ventricular paced beats can
significantly reduce cardiac output.
Dual chamber pacing modes
DOO (AV sequential asynchronous)
Both the atria and ventricles are asynchronously paced at a fixed rate with a programmed AV delay
(simulating the delay in the AV node during an endogenous beat). While mechanical efficiency is better
than in VOO due to recruitment of atriax, the ventricular depolarization from V-pacing spreads throughout
the ventricle in an abnormal manner. Mechanical efficiency of the ventricular contraction in a DOO mode
is usually less when compared to an impulse conducted through AV node and conduction system. AOO is
thus preferred for weaning from CPB if the conducting system is intact. DOO should be used in place of
atrial pacing if the patient has higher degree heart blocks and abnormalities of the conduction system. DOO
has a similar risk of R-on-T VF as in the other asynchronous modes (AOO and VOO).
VDD (P wave synchronous)
In this unique dual chamber mode, only the ventricle is paced. The pulse generator inhibits its
ventricular pacing in response to a sensed ventricular depolarization. A sensed atrial depolarization,
however, triggers ventricular pacing if no intrinsic ventricular depolarization is sensed. If the absence of
intrinsic atrial depolarization, ventricular pacing is initiated. The specific indication for VDD is AV node
block with an intact sinus node with the pacemaker serving as a circuit around the AV node
DVI (AV sequential, ventricular inhibited)
3
In DVI mode, sensing of an intrinsic ventricular depolarization (following either an atrial pacing
spike or intrinsic atrial depolarization), inhibits ventricular pacing. In the absence of any intrinsic cardiac
depolarization, the pacemaker behaves like a DOO. Since there is no atrial sensing, there is a possibility
that the atrial pacing stimulus will not be inhibited even though there is an intrinsic atrial rhythm. This may
lead to competition if the atrium is beating at a faster rate, and can precipitate atrial arrhythmias. For this
reason, DDI or DDD are preferable to DVI in patients with atrial rates high enough to compete with the
pacing rate. DVI is primarily used for immediate treatment of pacemaker-mediated tachycardia. If a
ventricular paced beat is conducted retrograde to the atria, atrial sensing might interpret this as intrinsic
atrial activity, which in DDI and DDD modes would precipitate a release of a ventricular stimulus creating
a ‘loop’ pacemaker-mediated tachycardia
DDI (AV sequential, non-P-synchronous, with dual chamber sensing)
DDI is an improvement over DVI as it includes atrial sensing, which prevents the possibility of the
atrial pacing stimulus competing with an intrinsic atrial rhythm. The maximum rate of paced stimuli is the
same as the minimum rate set on the pulse generator, a feature that distinguishes DDI from DDD mode. In
DDD, the maximal pacing rate is not the set lower rate limit; instead the ventricular pacing stimuli can be
delivered at a higher rate in order to 'track' atrial activity. DDI is thus better than DDD in the presence of
rapid atrial rates (arrhythmias), as since it avoids pacing the ventricle too rapidly. Indeed, most permanent
pacemakers set to DDD will automatically change to DDI if a too-rapid atrial rate is detected. Temporary
pulse generators will not do this automatically, but can be manually programmed to DDI in the setting of
the not-so-infrequent atrial tachycardias.
DDD (AV sequential, P-synchronous, dual chamber sensing, universal)
DDD is commonly used mode in patients with both atrial and ventricular pacing. Both the chambers can be
paced, sensed, triggered or inhibited depending upon the underlying electrical activity. DDD is probably
the most versatile pacing mode. However, there is a risk of ventricular tracking of atrial tachycardias in
DDD; most temporary pulse generators address this risk by allowing the setting of a 'maximum tracking
rate' or 'upper rate limit' or adjusting the PVARP.
VAT, AAT, DAT (Triggered modes)- These modes are rarely used in the immediate post-CPB period.
BiV pacing
Typically, single ventricle or AV sequential pacing is employed to treat the underlying
electrophysiologic or mechanical cardiac dysfunction after cardiac surgery. However, hemodynamic
benefits observed with single ventricle or AV sequential pacing can be limited, especially in patients with
substantial interventricular or intraventricular dyssynchrony. Patients with severely impaired left
ventricular (LV) function often demonstrate prolonged inter- and intraventricular conduction. Ventricular
dysynchrony can lead to decreased cardiac output, increased filing pressures, and diastolic mitral
regurgitationxi.
Biventricular (BiV) pacing and cardiac resynchronization therapy (CRT) have been shown to
improve systolic and diastolic function in non-surgical patients with congestive heart failure (CHF) and
conduction blockxii,xiii. These benefits have been quantified by the use of various hemodynamic and
echocardiographic modalities including 2-D, 3D echocardiography as well as tissue Doppler and strain
Doppler imaging. xiv,xv Several reports have also shown improvements in ventricular function in cardiac
surgical patients following BiV pacing (pacing leads on the RV and LV)1,2. In the majority of patients with
reduced LV function, temporary biventricular pacing improved CO and arterial blood pressure after
surgery, especially when LV dilatation was presentxvi. BiV pacing may reduce the need for excessive
inotropes and their side effects, intra-aortic balloon pumps, or ventricular assist devices in weaning from
cardiopulmonary bypass.
Intra-aortic balloon pump (IABP) timing and Pacing
Pacing stimuli may be misinterpreted by the IABP as QRS complexes. For isolated ventricular
pacing, this small timing discrepancy can be easily overcome by manual adjustment of the IABP timing
4
parameters. However, if both atrial and ventricular stimuli are misinterpreted as two separate QRS
complexes, timing adjustment may not be feasible. To avoid this problem, either the IABP should be timed
according to the arterial pulse, or high frequency filters should be applied to the EKG signal in the monitor.
This error is minimized with use of bipolar leads that have a smaller EKG signals as compared to unipolar
leads.
References:
i
ii
iii
iv
v
vi
vii
viii
ix
x
xi
xii
xiii
xiv
xv
xvi
Scherhag A, Gulbins H, Lange R, et al: Improved reliability of postoperative cardiac pacing by use of bipolar
temporary pacing leads. Eur JCPE 1995,5;401-403
Kashima I, Shin H, Yozu R, et al. Optimal positioning of temporary epicardial atrial pacing leads after cardiac
surgery. Jpn J Thorac Cardiovasc Surg. 2001 May;49(5):307-10.
Lewicka-Nowak E, Kutarski A, Dabrowska-Kugacka A, et al:Atrial lead location at the Bachmann's bundle
region results in a low incidence of far field R-wave sensing. Europace. 2008 Feb;10(2):138-46.
de Cock CC, Meyer A, Kamp O, et al. Hemodynamic benefits of right ventricular outflow tract pacing:
comparison with right ventricular apex pacing. Pacing Clin Electrophysiol. 1998 Mar;21(3):536-41.
Eberhardt F, Hanke T, Heringlake M, et al: Feasibility of temporary biventricular pacing in patients with reduced
left ventricular function after coronary artery bypass grafting. Pacing Clin Electrophysiol. 2007 Nov;30(11):1425.
Muehlschlegel JD, Peng YG, Lobato EB, et al. Temporary biventricular pacing post cardiopulmonary bypass in
patients with reduced ejection fraction. Card Surg. 2008 Jul-Aug;23(4):324-30.
Berberian G, Quinn TA, Kanter JP, et al: Optimized biventricular pacing in atrioventricular block after cardiac
surgery. Ann Thorac Surg. 2005 Sep;80(3):870-5.
Tanaka H, Okishige K, Mizuno T, Kuriu K, et al:Temporary and permanent biventricular pacing via left
ventricular epicardial leads implanted during primary cardiac surgery. Jpn J Thorac Cardiovasc Surg. 2002
Jul;50(7):284-9.
Durbin CG Jr, Kopel RF. Optimal atrioventricular (AV) pacing interval during temporary AV sequential pacing
after cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia 1993; 7: 316–20.
Hartzler GO, Maloney JD, Curtis JJ, Barnhorst DA. Hemodynamic benefits of atrioventricular sequential pacing
after cardiac surgery. Am J Cardiol. 1977 Aug;40(2):232-6.
Langer F, Tibayan FA, Rodriguez F, et al: Altered mitral valve kinematics with atrioventricular and ventricular
pacing. J Heart Valve Dis. 2005 May;14(3):286-94.
Linde C, Braunschweig F, Gadler F, et al. Long-term improvements in quality of life by biventricular pacing in
patients with chronic heart failure: results from the Multisite Stimulation in Cardiomyopathy study (MUSTIC).
Am J Cardiol. 2003 May 1;91(9):1090-5.
St John Sutton MG, Plappert T, Abraham WT, et al; Multicenter InSync Randomized Clinical Evaluation
(MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in
chronic heart failure. Circulation. 2003 Apr 22;107(15):1985-90.
Zhang Q, Yu CM, Fung JW, et al. Assessment of the effect of cardiac resynchronization therapy on
intraventricular mechanical synchronicity by regional volumetric changes. Am J Cardiol. 2005 Jan 1;95(1):126-9.
Sun JP, Chinchoy E, Donal E, et al. Evaluation of ventricular synchrony using novel Doppler echocardiographic
indices in patients with heart failure receiving cardiac resynchronization therapy. J Am Soc Echocardiogr. 2004
Aug;17(8):845-50.
Dzemali O, Bakhtiary F, Israel CW, et al: Impact of different pacing modes on left ventricular function following
cardiopulmonary bypass. Thorac Cardiovasc Surg. 2008 Mar;56(2):87-92.
5